ProShare Advisors
DTIL icon

ProShare Advisors’s Precision BioSciences DTIL Stock Holding History

ProShare Advisors’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-525
Closed -$48K – 1885
2022
Q1 		$48K Sell
525
-128
-20% -$17.4K ﹤0.01% 2117
2021
Q4 		$144K Buy
653
+17
+3% +$4.75K ﹤0.01% 2136
2021
Q3 		$220K Sell
636
-119
-16% -$40.3K ﹤0.01% 1746
2021
Q2 		$284K Buy
755
+99
+15% +$29.7K ﹤0.01% 1930
2021
Q1 		$204K Buy
656
+43
+7% +$15.1K ﹤0.01% 2030
2020
Q4 		$153K Buy
613
+142
+30% +$34.8K ﹤0.01% 1918
2020
Q3 		$87K Sell
471
-12
-2% -$2.39K ﹤0.01% 1535
2020
Q2 		$121K Buy
+483
New +$106K ﹤0.01% 1546
2020
Q1 		– Sell
-528
Closed -$220K – 1282
2019
Q4 		$220K Buy
+528
New +$166K ﹤0.01% 1526

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

ProShare Advisors's DTIL Position: Q2 2022 in Review

ProShare Advisors sold out of Precision BioSciences (DTIL) in Q2 2022, closing a stake of 525 shares — an estimated $48K sold.

ProShare Advisors first reported a position in DTIL in Q4 2019 and held it in 9 quarters. The position peaked at $284K in Q2 2021. 119 funds tracked by Wall St. Rank hold DTIL as of Q2 2022.

  • ProShare Advisors reported no remaining Precision BioSciences position as of Q2 2022 after selling out during the quarter.
  • ProShare Advisors sold 525 Precision BioSciences shares in Q2 2022, an estimated $48K.
  • ProShare Advisors first reported a position in Precision BioSciences in Q4 2019 and held it in 9 quarters.
  • ProShare Advisors's Precision BioSciences position peaked at $284K in Q2 2021.
  • 119 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2022.

Based on ProShare Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.